With 1.08 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.23 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $1.659 whereas the lowest price it dropped to was $1.255. The 52-week range on MYNZ shows that it touched its highest point at $14.39 and its lowest point at $1.21 during that stretch. It currently has a 1-year price target of $14.00. Beta for the stock currently stands at 0.26.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MYNZ was down-trending over the past week, with a drop of -4.23%, but this was down by -11.69% over a month. Three-month performance dropped to -19.53% while six-month performance fell -39.96%. The stock lost -68.52% in the past year, while it has lost -85.43% so far this year. EPS is expected to grow by 59.64% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -52.02%.
Float and Shares Shorts:
At present, 5.41 million MYNZ shares are outstanding with a float of 5.23 million shares on hand for trading. On 2025-10-31, short shares totaled 36944.0, which was 68.0 higher than short shares on 1759190400. In addition to Mr. Guido Baechler as the firm’s CEO & Executive Director, Dr. Christopher Von Toerne P.M.P., Ph.D. serves as its Chief Operating Officer.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With MYNZ analysts setting a high price target of 14.0 and a low target of 14.0, the average target price over the next 12 months is 14.0. Based on these targets, MYNZ could surge 929.41% to reach the target high and rise by 929.41% to reach the target low. Reaching the average price target will result in a growth of 929.41% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$10.84 being high and -$10.84 being low. For MYNZ, this leads to a yearly average estimate of -$10.84.
